BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Cipla
Julphar
Queensland Health
Harvard Business School
Dow
Chubb
Boehringer Ingelheim
Argus Health

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,295,675

« Back to Dashboard

Which drugs does patent 9,295,675 protect, and when does it expire?

Patent 9,295,675 protects VOGELXO and is included in one NDA.

This patent has seven patent family members in seven countries.
Summary for Patent: 9,295,675
Title:Testosterone gel compositions and related methods
Abstract: Described are gel compositions containing active pharmaceutical ingredient such as testosterone, solvent, and thickener, the gel compositions being useful for transdermal administration of the active ingredient to a patient, and related methods. Certain embodiments of the gel composition specifically exclude Hsieh enhancer.
Inventor(s): Pimplaskar; Harish K. (Charlotte, NC)
Assignee: Upsher-Smith Laboratories, Inc. (Maple Grove, MN)
Application Number:14/307,085
Patent Claim Types:
see list of patent claims
Composition; Compound; Delivery; Use;

Drugs Protected by US Patent 9,295,675

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Upsher-smith Labs VOGELXO testosterone GEL, METERED;TRANSDERMAL 204399-003 Jun 4, 2014 BX RX No No ➤ Subscribe ➤ Subscribe Y METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE ➤ Subscribe
Upsher-smith Labs VOGELXO testosterone GEL;TRANSDERMAL 204399-002 Jun 4, 2014 AB2 RX No No ➤ Subscribe ➤ Subscribe Y METHOD FOR TRANSDERMAL DELIVERY OF TESTOSTERONE ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 9,295,675

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,785,426 Testosterone gel compositions and related methods ➤ Subscribe
9,662,340 Testosterone gel compositions and related methods ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 9,295,675

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Singapore 11201604788U ➤ Subscribe
Israel 246134 ➤ Subscribe
Hong Kong 1223852 ➤ Subscribe
European Patent Office 3079703 ➤ Subscribe
Canada 2857286 ➤ Subscribe
Australia 2014362275 ➤ Subscribe
World Intellectual Property Organization (WIPO) 2015089289 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cipla
QuintilesIMS
UBS
Fuji
Citi
Argus Health
Johnson and Johnson
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot